中文
EN
News Center
News Center
Viwit Pharmaceuticals Granted "Radiation Safety License": A Dual Milestone in Compliance and Innovation
Author：
VIWIT
Release Time：
2026-01-22
We are proud to announce that Viwit Pharmaceuticals has recently obtained the Radiation Safety License for a Class B unsealed radioactive material workplace upon the approval of the Shandong Provincial Department of Ecology and Environment. Notably, we are the first company in Zaozhuang City and the second in Shandong Province to receive this certification. The acquisition of this license not only serves as an authoritative recognition of our capabilities in radiation safety management, technological application, and compliant operations, but also marks a significant step forward in Viwit's R&D and industrialization capabilities in the field of radiopharmaceuticals.
Radiopharmaceuticals play an irreplaceable role in areas such as oncology diagnosis and treatment. Their development and production, however, are subject to stringent radiation safety management requirements. The approval of the Radiation Safety License demonstrates that Viwit has met national standards in workplace design, protective measures, personnel training, and emergency management, enabling us to carry out radioisotope-related activities safely and efficiently. This achievement is the result of our continuous investment in technology accumulation, quality control, and risk prevention systems, and fully reflects our commitment to the principle of "Safety First, Innovation Driven."
As a key strategic initiative of Viwit in nuclear medicine, this certification will further accelerate our breakthroughs in radiopharmaceutical R&D and production. Moving forward, we will leverage this license to expedite the development of theranostic radiopharmaceuticals for oncology, providing more precise and efficient solutions for clinical practice.
This breakthrough in radiation safety not only validates Viwit's technical strengths, but also establishes a benchmark for standardized development within the radiopharmaceutical industry. As nuclear medicine continues to gain importance in precision medicine, Viwit is dedicated to bringing new hope to patients worldwide through safer and more advanced technologies.
From laboratory research to industrial application, from targeted breakthroughs to integrated value-chain development, Viwit is taking solid steps forward in writing a new chapter for innovative drug development in China. The Radiation Safety License stands as a key milestone in this inspiring journey.